摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aR,4R,9S,10E,11aS)-4-heptyl-3a,4,7,8,9,11a-hexahydro-9-hydroxy-2,2-dimethyl-6H-[1,3]dioxolo[4,5-c]oxecin-6-one | 1456623-99-6

中文名称
——
中文别名
——
英文名称
(3aR,4R,9S,10E,11aS)-4-heptyl-3a,4,7,8,9,11a-hexahydro-9-hydroxy-2,2-dimethyl-6H-[1,3]dioxolo[4,5-c]oxecin-6-one
英文别名
(3aR,4R,9S,11aS,E)-4-heptyl-9-hydroxy-2,2-dimethyl-7,8,9,11a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]oxecin-6(4H)-one;(3aR,4R,9S,10E,11aS)-4-heptyl-9-hydroxy-2,2-dimethyl-3a,4,7,8,9,11a-hexahydro-[1,3]dioxolo[4,5-c]oxecin-6-one
(3aR,4R,9S,10E,11aS)-4-heptyl-3a,4,7,8,9,11a-hexahydro-9-hydroxy-2,2-dimethyl-6H-[1,3]dioxolo[4,5-c]oxecin-6-one化学式
CAS
1456623-99-6
化学式
C19H32O5
mdl
——
分子量
340.46
InChiKey
KDEFQBVNCUPVNQ-ZXZQLWFOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.84
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A Carbohydrate-Based Approach for the Total Synthesis of Xyolide
    作者:Debendra Mohapatra、D. Reddy、Dnyaneshwar Karhale、Jhillu Yadav
    DOI:10.1055/s-0033-1339896
    日期:——
    We have achieved a total synthesis of xyolide, a bioactive nonenolide, by following a carbohydrate-based approach starting from d -(–)-ribose. The key reactions involved epoxide opening with a long-chain aliphatic Grignard reagent, Yamaguchi esterification, and a ring-closing-metathesis reaction. The longest linear sequence was nine steps and the overall yield was 30%.
    通过从 d -(-)-核糖开始,采用基于碳水化合物的方法,我们已经实现了木内酯(一种生物活性壬烯醇内酯)的全合成。关键反应包括环氧化物与长链脂肪族格氏试剂的开环、山口酯化和闭环复分解反应。最长的线性序列为 9 步,总产率为 30%。
  • Asymmetric synthesis of naturally occurring nonenolide xyolide through cross metathesis and macrolactonization reaction
    作者:Rohan Kalyan Rej、Anuvab Jana、Samik Nanda
    DOI:10.1016/j.tet.2014.02.072
    日期:2014.4
    Asymmetric total synthesis of xyolide, a small ring macrolide is presented in this article. The synthesis is achieved through an 'E' selective cross metathesis (CM) reaction between two appropriate fragments followed by lactonization by Shiina method. One of the fragments containing 7S,8S,9R stereocenters of xyolide is accessed from n-nonanal by adopting an organocatalytic asymmetric alpha-aminooxylation, Z-selective Ando olefination, and substrate directed dihydroxylation reaction. The other fragments containing 4S stereocenter was prepared by ME-DKR (metal enzyme combined dynamic kinetic resolution) method. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 17-苯基-18,19,20-三去甲-前列腺素F2-alpha1,15-内酯 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (R)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 8-Chlor-1,6-benzodioxocin 2,2,6-Trifluoro-4-phenyl-3-trifluoromethyl-2H-pyran 2,3,4,5,6,7-Hexahydro-1-benzoxonin aspinolide C 4-deutero-4,5-dihydro-2H-benzo[b]oxocin-6(3H)-one 3-Carbethoxy-4-bromo-5,6-dihydro-2-pyron (E,8S,13S)-8,13-diisopropyl-5,8,9,12,13,16-hexahydro-6,15-dioxa-benzocyclotetradecene-7,14-dione (1S,7Z,10R,11S)-11-t-butyldimethylsolyloxy-4-oxabicyclo[8.3.0]tridec-7-en-3-one (Z)-2-Methyl-3a,4,5,6,7,9a-hexahydro-cycloocta[b]furan-3-carboxylic acid ethyl ester (5R,8S,9R,10S,E)-5,8,9-trihydroxy-10-methyl-3,4,5,8,9,10-hexahydro-2H-oxecin-2-one 19,21-Dimethyl-4,15-dioxa-bicyclo[16.2.2]docosa-1(21),18(22),19-triene-3,16-dione (1S,4aR,8aS)-1,4,4a,8a-Tetrahydro-naphthalen-1-ol 5-methyl-2-oxo-2H-cyclohepta[b]furan-3-carboxylic acid methyl ester trans,trans-2,3;10,11-Dibenzo-1,4,9,12-tetraoxa-cyclohexadecatetraen-(2,6,10,14) 1-C-(4-O-acetyl-2,3,6-trideoxy-β-L-erytro-hex-2-en-pyranosyl)-3-bromopentane 2,2,2-Trichloro-acetimidic acid (2S,3S,6R)-2-methoxy-6-methyl-3,6-dihydro-2H-pyran-3-yl ester 1-C-(4-O-acetyl-2,3,6-trideoxy-α-L-erytro-hex-2-en-pyranosyl)-5-bromopentane (3,4-dihydro-1H-2-benzopyran-7-yl)methanesulfonylchloride methyl 2,3-C-(2-butene-1,4-diyl)-2,3-dideoxy-α,β-D-talofuranoside 3-oxobicyclo<7.3.1>-trideca-1(12),9(10)-diene-(ZZ)-12-carboxylic acid (3aS,5S,6R,8aR)-6-Hydroxy-5-methyl-3,3a,4,5,6,8a-hexahydro-cyclohepta[b]furan-2-one (Z)-3-butyl-6,7,8,9-tetrahydrooxonin-2(5H)-one 3,6-dihydro-4-methyl-2H-1-benzoxocine 18,20-Dimethyl-4,14-dioxa-bicyclo[15.2.2]henicosa-1(20),17(21),18-triene-3,15-dione 3-butyl-5,6,7,8,9,10-hexahydro-2H-oxecin-2-one